{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T08:27:55Z","timestamp":1749544075523,"version":"3.40.5"},"reference-count":79,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cytopathology"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is growing evidence that molecular testing is feasible on all types of cytological preparation, which is fortunate as more diagnostic markers and biomarkers for targeted therapies are discovered for use in pulmonary and pleural malignancies. In this article we will discuss the pre\u2010analytic, analytic, and post\u2010analytic (interpretive) considerations for successful implementation of molecular tests for diagnostic and predictive markers in respiratory and pleural cytology. The vast majority of laboratories are familiar with, and have validated their molecular protocols for, formalin\u2010fixed paraffin\u2010embedded surgical specimens, which are not directly applicable to cytology specimens. Thus, rigorous validation must be performed for each type of fixative and cytology preparation before it is implemented in the clinical setting.<\/jats:p>","DOI":"10.1111\/cyt.13045","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T17:45:13Z","timestamp":1627839913000},"page":"14-22","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular cytology of the respiratory tract and pleura"],"prefix":"10.1111","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5542-2994","authenticated-orcid":false,"given":"Fang","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Pathology New York University Langone Health New York NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Shum","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology Department of Medicine New York University Langone Health New York NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1857-3774","authenticated-orcid":false,"given":"Andre L.","family":"Moreira","sequence":"additional","affiliation":[{"name":"Department of Pathology New York University Langone Health New York NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2017-0388-CP"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22291"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.4103\/2231-0770.83719"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318227142d"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31820517a3"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/dc.23318"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.633923"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0119-CP"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.5858\/133.5.743"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21871"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2011.05.011"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0250-CP"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2013.92"},{"key":"e_1_2_10_15_1","unstructured":"U.S. Food and Drug Administration.Considerations for design development and analytical validation of next generation sequencing (NGS) \u2013 Based In Vitro Diagnostics (IVDs) intended to aid in the diagnosis of suspected germline diseases.https:\/\/www.fda.gov\/media\/99208\/download. Last updated 13 April 2018. Accessed 8 May 2021."},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000497187"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.21037\/shc.2019.11.14"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21276"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/dc.23975"},{"issue":"6","key":"e_1_2_10_20_1","first-page":"550","article-title":"Endosonography with 25\u2010gauge core needles for immunohistochemistry and molecular testing in lung cancer patients: a feasibility study","volume":"130","author":"Misiaszek M","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2017.11.010"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22001"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2018.11.023"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2019.07.007"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2020.06.010"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/dc.20587"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0108-RA"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1142"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2020.08.019"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.07.006"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6671"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0155"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21660"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21815"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2013-0610-CP"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2020.12.002"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-20-676"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa980"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-02995-2"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654"},{"key":"e_1_2_10_41_1","unstructured":"NCCN guidelines version 5.2021 non\u2010small cell lung cancer.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae)https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf. Accessed 23 June 2021."},{"key":"e_1_2_10_42_1","unstructured":"Merck & Co Inc. Keytruda (pembrolizumab) [package insert].U.S. Food and Drug Administration website.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/125514s071s090lbl.pdf. Revised June 2020. Accessed 8 May 2021."},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.12.005"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.92"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.12.005"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22085"},{"key":"e_1_2_10_47_1","unstructured":"U.S. Food and Drug Administration.VENTANA ALK (D5F3) CDx Assay Premarket Approval Order Number P140025 Supplement Number S014.https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P140025S014. Last updated 3 March 2021. Accessed 8 May 2021."},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1159\/000498889"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22137"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.03.024"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0157-RA"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.05.013"},{"key":"e_1_2_10_53_1","unstructured":"HirschFRPD\u2010L1 IHC Blueprint Project: ongoing progress toward consistency among assays. 2018;https:\/\/www.iaslc.org\/iaslc\u2010news\/ilcn\/pd\u2010l1\u2010ihc\u2010blueprint\u2010project\u2010ongoing\u2010progress\u2010toward\u2010consistency\u2010among\u2010assays. Accessed 14 December 2018."},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/01478885.2020.1823105"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/cyt.12795"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.12.107"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa073"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqy164"},{"key":"e_1_2_10_59_1","first-page":"jclinpath\u20102021\u2010","article-title":"Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non\u2010small\u2010cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy","author":"Faber E","year":"2021","journal-title":"J Clin Pathol"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22324"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22155"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092084"},{"key":"e_1_2_10_63_1","unstructured":"IASLC Lung Cancer News.PD\u2010L1 in cytology specimens.https:\/\/www.iaslc.org\/iaslc\u2010news\/ilcn\/pd\u2010l1\u2010cytology\u2010specimensUpdated 10 December 2019. Accessed 8 May 2021."},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2018.02.003"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-03011-3"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318198d666"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21761"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1159\/000510323"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.10.023"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.10.009"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2016.10.006"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22398"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03031-7"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.11.29"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20317"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/dc.23491"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0240-SA"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22221"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPT94JVWIHBKRD"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2020.12.005"}],"container-title":["Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cyt.13045","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cyt.13045","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cyt.13045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T06:01:06Z","timestamp":1692856866000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cyt.13045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1111\/cyt.13045"],"URL":"https:\/\/doi.org\/10.1111\/cyt.13045","archive":["Portico"],"relation":{},"ISSN":["0956-5507","1365-2303"],"issn-type":[{"type":"print","value":"0956-5507"},{"type":"electronic","value":"1365-2303"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"assertion":[{"value":"2021-05-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}